GNR-069 ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
63Idiopathic thrombocytopenic purpura1

63. Idiopathic thrombocytopenic purpura


Clinical trials : 363 Drugs : 212 - (DrugBank : 43) / Drug target genes : 47 - Drug target pathways : 138
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05220878
(ClinicalTrials.gov)
September 9, 202121/1/2022Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With Chronic ITPMulticenter Randomized Double-blind Comparative Study of Clinical Efficacy and Safety of GNR-069 (JSC GENERIUM, Russia) and Nplate (Amgen Europe BV, The Netherlands) in Patients With Chronic Idiopathic Thrombocytopenic PurpuraIdiopathic Thrombocytopenic PurpuraBiological: GNR-069;Biological: NplateAO GENERIUMNULLRecruiting18 Years75 YearsAll160Phase 3Russian Federation